logo
Chronic Absenteeism's Post-COVID ‘New Normal': Data Shows It Is More Extreme

Chronic Absenteeism's Post-COVID ‘New Normal': Data Shows It Is More Extreme

Yahoo03-06-2025

The percentage of students with good attendance fell sharply between 2019 and 2023, while the share of chronically absent students more than doubled, offering further evidence of the pandemic's shattering effect on the nation's classrooms.
A new analysis of data from three states — North Carolina, Texas and Virginia — shows that prior to COVID, 17% of students were chronically absent, meaning they missed at least 10% of the school year. By 2023, long after schools had to cope with new variants and hybrid schedules, that figure hit 37%.
'Absences are both more common for everybody, but they are also more extreme,' said Jacob Kirksey, an associate professor of education policy at Texas Tech University.
Additional new research shows that while post-pandemic chronic absenteeism lingers across the board, rates were substantially higher for low-income students. In North Carolina, for example, the chronic absenteeism rate for students in poverty before the pandemic was 9.2 percentage points higher than for non-poor students. By 2023, the gap increased to 14.6 percentage points.
'The income gap really was the main driver that showed up over and over again,' said Morgan Polikoff, an education researcher at the University of Southern California. But it's hard for schools to make a dent in the problem, he said, if they aren't investigating the reasons for chronic absenteeism. 'There's a big difference between the kid [who] has an illness and is chronically sick versus the kid [who] is super disengaged.'
Kirksey and Polikoff were among several researchers who shared their findings Friday at an American Enterprise Institute event focused on facing what Kirksey called the 'under-the-hood dynamics' of chronic absenteeism in the post-COVID era. Since 2022, when the national average peaked at 28%, the rate has dropped to 23% — still much higher than the pre-COVID level of about 15%, according to the conservative think tank's tracker.
'I have a question that keeps me up at night. That question is 'What's the new normal going to be?' ' said Nat Malkus, the deputy director of education policy at AEI. 'We see this rising tide, but I think that it's incumbent on us to say that chronic absenteeism still affects disadvantaged students more.'
The research project began in September with the goal of offering guidance to districts in time for students' return to school this fall. The researchers stressed that those most likely to be chronically absent this school year — low-income, highly mobile and homeless students — are the same ones who will frequently miss school next year.
'Absenteeism should seldom come as a surprise,' said Sam Hollon, an education data analyst at AEI. 'It's hard to justify delaying interventions until absences have accumulated.'
One new finding revealed Friday contradicts a theory that gained traction following the pandemic — that students were more likely to be absent if their teachers were also out. As with students, teacher absenteeism increased during the pandemic and hasn't returned to pre-COVID levels.
The relationship between teacher absences and student absences, however, is 'pretty negligible,' said Arya Ansari, an associate professor of human development and family science at The Ohio State University.
'These absences among teachers don't actually contribute to the post-COVID bump that we've seen in student absences,' he said. 'Targeting teacher absences isn't going to move the needle.'
Related
The researchers discussed how even some well-intentioned responses to the COVID emergency have allowed chronic absenteeism to persist. States, Malkus said, made it easier to graduate despite frequent absences and missing school doesn't necessarily prevent students from turning in their work.
'In my day, you had to get a packet and do the work at home' if you were absent, Polikoff said. In interviews with 40 families after the pandemic, 39 said it was easy to make up work because of Google Classroom and other online platforms. 'How many said, 'Let's make it harder'? Zero.'
In another presentation, Ethan Hutt, an associate education professor at the University of North Carolina, estimated that chronic absenteeism accounts for about 7.5% of overall pandemic learning loss and about 9.2% for Black and low-income students — a 'nontrivial, but modest' impact.
He stressed that missing school also affects student engagement and relationships with teachers. While technology has made it easier for students to keep up, 'there may be other harms that we want to think about and grapple with,' he said.
Related
The new research comes as states are mounting new efforts to more closely track chronic absenteeism data and share it with the public. In 2010, only one state — Maryland — published absenteeism data on its state education agency website. Now, 49 states — all but New Hampshire — report rates on an annual, monthly or even daily basis, according to a new report released Tuesday by Attendance Works, an advocacy and research organization.
The systems allow educators and the public to more quickly identify which students are most affected and when spikes occur. Rhode Island, Connecticut, Massachusetts and Washington D.C. post rates even before the end of the school year. Rhode Island offers real-time data, while Connecticut publishes monthly reports.
The New Hampshire Department of Education doesn't monitor chronic absenteeism, but has a statewide 92.7% attendance rate, a spokesperson said.
The report highlights states that have taken action to reduce chronic absenteeism. In Virginia, bus drivers ensure their routes include students who might be more likely to struggle with transportation. With state funds, Fauquier County, west of Washington, D.C., opened a center for students on short-term suspension to minimize the absences that tend to pile up when a student is removed from the classroom.
Overall chronic absenteeism in the state declined from 19.3% in 2022-23 to 15.7% in 2023-24. To Hedy Chang, executive director of Attendance Works, such improvement proves 'we can still get things done in our country and in education, despite all of the culture wars and binary thinking.'
Some district and school leaders have looked to their peers for ideas on how to get kids back in school. After participating in a six-month program with 16 other districts across the country organized by the nonprofit Digital Promise, Mark Brenneman, an elementary principal in New York's Hudson City Schools, started interviewing families about their challenges.
He learned that Hispanic parents often keep their children home when it rains because they're worried they're going to catch a cold. Several had transportation challenges. His school, Smith Elementary, even contributed to the problem, he said, by holding concerts, award ceremonies or other family events in the morning. Parents would come to celebrate their children's accomplishments, then take them out for lunch and not return.
Related
Hudson, about 40 miles south of Albany, has undergone significant change since the pandemic, added Superintendent Juliette Pennyman. Some families leaving New York City have settled in Hudson, driving up the cost of housing.
'Our families are being priced out of the community,' she said. 'Housing insecurity was … affecting families' and students' ability to focus on school.'
As a result of the intense focus on the issue, Smith, which had a 29% chronic absenteeism rate last year, has seen an about a 15% increase in the number of students with good attendance.
'It's not like we're down to like 10% chronically absent,' Brenneman said. 'But we've hammered away.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine
Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine

Miami Herald

time2 hours ago

  • Miami Herald

Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine

mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older CAMBRIDGE, MA / ACCESS Newswire / June 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced positive results from a Phase 3 efficacy study (P304) evaluating the relative vaccine efficacy (rVE) against influenza illness of mRNA-1010, the Company's seasonal influenza (flu) vaccine candidate, compared to a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older. mRNA-1010 achieved the most stringent superiority criterion prespecified in the protocol, with an rVE of 26.6% (95% CI; 16.7%, 35.4%) in the overall study population. Additionally, strong rVE was observed for each influenza strain contained in the vaccine, including A/H1N1 (rVE=29.6%), A/H3N2 (rVE=22.2%), and the B/Victoria lineages (rVE=29.1%). Subgroup analyses confirmed a consistently strong rVE point estimate across age groups, risk factors and previous influenza vaccination status. In participants aged 65 years and older, mRNA-1010 demonstrated an rVE of 27.4%. "Today's strong Phase 3 efficacy results are a significant milestone in our effort to reduce the burden of influenza in older adults. The severity of this past flu season underscores the need for more effective vaccines," said Stéphane Bancel, Chief Executive Officer of Moderna. "An mRNA-based flu vaccine has the potential advantage to more precisely match circulating strains, support rapid response in a future influenza pandemic, and pave the way for COVID-19 combination vaccines." In a previous Phase 3 study, mRNA-1010 had already demonstrated superior seroconversion rates and geometric mean titer ratios (GMR) against all strains included in the vaccine compared to both high-dose and standard-dose licensed seasonal influenza vaccine. [1] According to the CDC, seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-2025 season. [2] More than 600,000 Americans were hospitalized due to flu-related illness last year, leading to substantial direct and indirect costs, as well as widespread disruption to daily life and work. [3] P304 ( NCT06602024 ) is a Phase 3, randomized, observer-blind, active-controlled, case-driven, pivotal efficacy, immunogenicity and safety study. The trial enrolled 40,805 adults aged 50 years and older across 11 countries. Participants were randomly assigned to receive either a single dose of mRNA-1010 or a standard-dose licensed comparator, with a median follow-up of six months. Safety and tolerability of mRNA-1010 were consistent with reported results from a previous Phase 3 study. [4] The majority of solicited adverse reactions (SARs) were mild. Injection site pain was the most common local SAR, and fatigue, headache and myalgia were the most common systemic SARs reported. There were no significant differences between the groups in the rates of unsolicited adverse events, serious adverse events, or adverse events of special interest. Moderna plans to present these data at an upcoming medical conference and submit for peer-reviewed publication. The Company will engage with regulators on filing submissions for mRNA-1010. About Moderna Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines. Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: Moderna's engagement with regulators on filing submissions for its standalone flu vaccine candidate; and the efficacy, safety and tolerability of mRNA-1010. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna's control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading "Risk Factors" in Moderna's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission, which are available on the SEC's website at . Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna's current expectations and speak only as of the date of this press release. Moderna Contacts Media: Chris RidleyHead of Global Media Relations+1 Investors: Lavina TalukdarSenior Vice President & Head of Investor Relations+1 SOURCE: Moderna, Inc.

Stocks making the biggest moves premarket: Meta, Moderna, Hewlett Packard Enterprise, Juniper Networks and more
Stocks making the biggest moves premarket: Meta, Moderna, Hewlett Packard Enterprise, Juniper Networks and more

CNBC

time2 hours ago

  • CNBC

Stocks making the biggest moves premarket: Meta, Moderna, Hewlett Packard Enterprise, Juniper Networks and more

Check out the companies making headlines before the bell: Moderna — Shares rose 2% after the biotech company's experimental flu vaccine showed a positive response in a late-stage trial, opening the way for the standalone shot and a combination Covid shot. Hewlett Packard Enterprise , Juniper Networks — Shares rallied 14% and 8%, respectively, after the U.S. Department of Justice, according to court filings, settled its lawsuit challenging server maker Hewlett Packard Enterprise' $14 billion acquisition of Juniper Networks. Meta Platforms — Shares gained 2% after Bloomberg and The Information over the weekend reported, citing unnamed sources, that Meta has hired four artificial intelligence researchers from OpenAI to join its new Superintelligence group led by Alexandr Wang. Those hires are Jiahui Yu, Shuchao Bi, Shengjia Zhao and Hongyu Ren, the report said. Palantir Technologies , Accenture — Shares rose about 5% and 1%, respectively, after Palantir and Accenture said Accenture Federal will be Palantir's preferred implementation partner to help its U.S. federal government clients use AI to automate operations. Walt Disney — The entertainment stock rose 2% after being upgraded to buy from hold at Jefferies. The investment firm said Disney's parks business is holding up well and that the cruise revenue could jump in 2026 when two new ships are launched. Tesla — Shares fell about 1% as President Donald Trump's spending bill cleared a key hurdle over the weekend to move closer to the president's desk. The development adds pressure to renewables and electric vehicles as the latest changes in the bill would accelerate a phase out of clean energy manufacturing tax credits. — CNBC's Michelle Fox and Jesse Pound contributed reporting

Plan B for the Ultra-Rich: Why Global Citizenship Is Now a Strategic Asset
Plan B for the Ultra-Rich: Why Global Citizenship Is Now a Strategic Asset

Yahoo

time3 hours ago

  • Yahoo

Plan B for the Ultra-Rich: Why Global Citizenship Is Now a Strategic Asset

The ultra-wealthy are seeking more than just financial diversification, they want freedom, security, and control over their futures. Increasingly, that means investing in a second passport which is now considered a necessity among the ultra-wealthy. According to Armand Arton, CEO of global advisory firm Arton Capital, second residencies or passports are no longer simply lifestyle upgrades, they're strategic investments. 'A second residency or citizenship has become one of the most coveted assets among the ultra-wealthy,' Arton explains. 'It's driven by ambitions for improved mobility, security, and futureproofing. For many, it's a hedge against uncertainty.' Once the domain of jetsetters seeking easier travel, second citizenship has evolved into a powerful tool of geopolitical insurance. But mobility is only one piece of the puzzle. 'Acquiring a European Golden Visa, for example, grants access to the Schengen Zone and Europe's most dynamic markets. This empowers high-net-worth individuals to expand their businesses, explore new opportunities, and enjoy unrestricted travel,' says Arton. But the motivations go deeper. Security, both personal and financial has become paramount. 'Elections, pandemics, and the climate crisis serve as a stark reminder of how quickly freedoms can be revoked and situations can change,' he adds. 'Second residencies and citizenships now act as a crucial hedge against geopolitical uncertainty and economic instability.' Over the past ten years, demand for second citizenships has surged, particularly in response to crises. 'Each year, interest in Golden Visa and Citizenship by Investment Programmes grows by around 15–20%,' Arton notes. 'The conflict in Ukraine and the outbreak of Covid-19 were major catalysts. And we're likely to see a similar uptick in response to tensions currently gripping the Middle East.' What's more, the industry itself has evolved. 'It has matured. Programmes are becoming more tailored to each country's needs. There are a large number available investors are spoilt for choice.' Arton predicts similar trends will follow in response to rising tensions in the Middle East and elsewhere. 'Savvy investors are always looking ahead. When uncertainty spikes, demand for second citizenship rises with it.' While financial advantages are often cited, Arton stresses that wealth migration isn't solely about reducing tax burdens. 'There's a common misconception that taxation is the main driver. In reality, clients are usually motivated by freedom, security, or a lifestyle upgrade.' Still, taxation can play a role, especially in countries where citizenship programmes offer favourable treatment. 'Latvia, for example, has a 20% capital gains tax and no wealth tax for non-residents. Italy offers a flat-tax option on foreign income,' says Arton. 'But benefits vary based on an investor's home country. American citizens, for instance, are still taxed on their worldwide income, no matter where they live.' As the investment migration industry matures, it's also integrating more deeply into wealth management strategies. No longer seen as a fringe add-on, global citizenship is now a pillar of high-net-worth planning. 'It complements traditional financial planning by offering geographical diversification, market access, and personal security,' Arton explains. Clients often invest in real estate or government funds to qualify. 'These investments not only diversify portfolios but also shield assets from economic volatility. Perhaps most importantly, they provide long-term benefits for family members from access to healthcare and education, to global mobility.' This isn't just about protecting money, it's about preserving legacy. Arton Capital positions itself not just as a facilitator, but as a thought leader. 'We've advised over 13 governments on citizenship and visa policy. We want investment migration to benefit both our clients and the host countries,' says Arton. That level of influence means Arton Capital has a hand in shaping how programmes are designed and how they function ensuring they benefit both investors and host countries. He notes, 'We want to be at the forefront of this evolution.' The real power of second citizenship becomes most visible in moments of crisis. Arton recalls one case from recent years: 'During the political unrest in Hong Kong, where protestors clashed with police and uncertainty loomed, we helped a client gain citizenship in Antigua. With his new passport, he relocated almost immediately, avoided the fallout, and continued operating his business from a stable environment.' That kind of agility, the ability to move, adapt, and safeguard your family or business is the ultimate utility of investment migration. One of Arton Capital's most recent initiatives saw the firm collaborate with Techcombank Private, one of Vietnam's largest banks, on a series of 'Wealth Management and Global Investment Opportunity' seminars. 'We were selected as their exclusive strategic adviser,' says Arton. 'Vietnam's HNWIs are increasingly looking for global diversification, and we helped educate their teams on how second citizenship fits into that strategy.' With most of Vietnam's wealthy banking through Techcombank, the partnership made sense. 'They're seeing major growth in their foreign exchange business VND 100bn last year, aiming for 500bn in 2025, and 1,00bn by 2026. These citizenship services are key drivers in that FX growth.' Looking ahead, Arton Capital is turning its focus toward other fast-growing Asian markets. 'We're especially interested in Thailand, Cambodia, and Malaysia,' Arton says. 'These countries have a growing upper-middle class and high-net-worth population. Many are now seeking outbound mobility.' At the same time, these countries are developing their own inbound residency programmes like Thailand's Elite Visa and Malaysia's 'My Second Home' scheme, suggesting strong potential both for incoming and outgoing investment. More broadly, the forces driving demand for second citizenship show no signs of slowing. 'With a geopolitical crisis unfolding in the Middle East, economic uncertainty across global markets, and ongoing political turmoil, the demand for a 'Plan B' has never been greater,' Arton concludes. "Plan B for the Ultra-Rich: Why Global Citizenship Is Now a Strategic Asset" was originally created and published by Private Banker International, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store